Association Between Sleep Quality and Cirrhotic Cardiomyopathy: A Prospective Case-Control Study [PDF]
Nature and Science of SleepFei Liu,1,* Tianqing Cao,1,* Yacong Liu,1 Dian Huang,2 Jingxin Zhang3 1Department of Cardiology, Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, 225001, People’s Republic of China; 2Department of Radiology,
Liu F, Cao T, Liu Y, Huang D, Zhang J
doaj +2 more sources
Cirrhotic cardiomyopathy [PDF]
Journal of Hepatology, 2018 The article presents some data on the pathogenesis, clinical manifestations, main therapeutic approaches and methods of surgical treatment of cirrhotic cardiomyopathy (CCM).
Søren, Møller, Samuel S, Lee
+5 more sources
Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats [PDF]
Clinical and Molecular Hepatology, 2022 Background/Aims Galectin-3 plays a key pathogenic role in cardiac hypertrophy and heart failure. The present study aimed to investigate the effects of galectin-3 on cardiomyopathy – related factors and cardiac contractility in a rat model of cirrhotic ...
Ki Tae Yoon +4 more
doaj +1 more source
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS
Hepatology, EarlyView., 2022 The river diagram demonstrates that after transjugular intrahepatic portosystemic shunt insertion (TIPS) the majority of patients without ascites and 50% of the patients with ascites detectable at ultrasound, show the best response in the long term follow‐up.
Alexander Queck +14 more
wiley +1 more source
Incidence of Cirrhotic Cardiomyopathy among Hundred Patients of Tamil Nadu, IndiaA Cross-sectional Study [PDF]
Journal of Clinical and Diagnostic Research, 2020 Introduction: Cardiac dysfunction in cirrhosis may affect quality of life, prognosis and also may aggravate the course in patients undergoing invasive procedures such as surgery, insertion of a Transjugular Intrahepatic Portosystemic Shunts (TIPS ...
AK KOUSHIK, P GANESH, S SHANMUGANATHAN
doaj +1 more source
Pathogenic Mechanisms Underlying Cirrhotic Cardiomyopathy. [PDF]
Front Netw Physiol, 2022 Cardiac dysfunction associated with cirrhosis in the absence of preexisting heart disease is a condition known as cirrhotic cardiomyopathy (CCM). Cardiac abnormalities consist of enlargement of cardiac chambers, attenuated systolic and diastolic contractile responses to stress stimuli, and repolarization changes.
Liu H, Nguyen HH, Yoon KT, Lee SS.
europepmc +3 more sources
Cirrhotic cardiomyopathy: An independent prognostic factor for cirrhotic patients [PDF]
Clinical and Molecular Hepatology, 2018 Yun Bin Lee, Jeong-Hoon Lee
doaj +4 more sources
Frequency of Cardiomyopathy in Patients with Hepatic Cirrhosis [PDF]
JLUMHS, 2021 OBJECTIVE: To determine the frequency of cardiomyopathy and its manifestations in patients with liver cirrhosis presenting at Tertiary Care Hospital, Karachi.
Mahmood Jafri +5 more
doaj +1 more source
Right Heart Remodeling in Patients with End-Stage Alcoholic Liver Cirrhosis: Speckle Tracking Point of View [PDF]
, 2019 BACKGROUND: Data regarding cardiac remodeling in patients with alcoholic liver cirrhosis are scarce. We sought to investigate right atrial (RA) and right ventricular (RV) structure, function, and mechanics in patients with alcoholic liver cirrhosis.
Braun, Alexander +8 more
core +1 more source
Cirrhotic cardiomyopathy [PDF]
Clinical Liver Disease, 2013 The occurrence of systemic hemodynamic abnormalities in cirrhosis has been recognized for more than half a century. These hemodynamic changes consist of a reduced peripheral vascular resistance and a compensatory increase in cardiac output leading to the hyperdynamic circulatory syndrome.
openaire +2 more sources